- Home
- KNSA vs CMPO Comparison
KNSA vs CMPO Comparison
Compare KNSA & CMPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | CMPO |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | KNSA | CMPO |
|---|---|---|
| Price | $38.58 | $21.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $51.33 | $25.50 |
| AVG Volume (30 Days) | 510.1K | ★ 1.1M |
| Earning Date | 02-24-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $597,973,000.00 | $160,683,000.00 |
| Revenue This Year | $61.60 | $12.53 |
| Revenue Next Year | $29.82 | $9.95 |
| P/E Ratio | $88.08 | ★ N/A |
| Revenue Growth | ★ 55.68 | N/A |
| 52 Week Low | $17.82 | $9.24 |
| 52 Week High | $44.42 | $26.78 |
Technical Indicators
Market Signals| Indicator | KNSA | CMPO |
|---|---|---|
| Relative Strength Index (RSI) | 36.23 | 60.18 |
| Support Level | $39.16 | $20.15 |
| Resistance Level | $43.00 | $23.60 |
| Average True Range (ATR) | 1.70 | 0.93 |
| MACD | -0.29 | 0.25 |
| Stochastic Oscillator | 6.41 | 58.24 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About CMPO CompoSecure Inc.
CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform. It has two reportable segments: Payment Card and Arculus.